State of the art in epitope mapping and opportunities in COVID-19
| dc.Affiliation | October university for modern sciences and Arts MSA | |
| dc.contributor.author | Hamed, Samira M | |
| dc.contributor.author | Sakr, Masarra M | |
| dc.contributor.author | El-Housseiny, Ghadir S | |
| dc.contributor.author | Wasfi, Reham | |
| dc.contributor.author | Aboshanab, Khaled M | |
| dc.date.accessioned | 2023-03-10T08:58:36Z | |
| dc.date.available | 2023-03-10T08:58:36Z | |
| dc.date.issued | 2023-03-06 | |
| dc.description | SJR 2024 0.536 Q2 H-Index 47 | |
| dc.description.abstract | The understanding of any disease calls for studying specific biological structures called epitopes. One important tool recently drawing attention and proving efficiency in both diagnosis and vaccine development is epitope mapping. Several techniques have been developed with the urge to provide precise epitope mapping for use in designing sensitive diagnostic tools and developing rpitope-based vaccines (EBVs) as well as therapeutics. In this review, we will discuss the state of the art in epitope mapping with a special emphasis on accomplishments and opportunities in combating COVID-19. These comprise SARS-CoV-2 variant analysis versus the currently available immune-based diagnostic tools and vaccines, immunological profile-based patient stratification, and finally, exploring novel epitope targets for potential prophylactic, therapeutic or diagnostic agents for COVID-19. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21100854839&tip=sid&clean=0 | |
| dc.identifier.citation | Hamed, S. M., Sakr, M. M., El-Housseiny, G. S., Wasfi, R., & Aboshanab, K. M. (2023). State of the art in epitope mapping and opportunities in COVID-19. Future Science OA, 9(1). https://doi.org/10.2144/fsoa-2022-0048 | |
| dc.identifier.doi | https://doi.org/10.2144/fsoa-2022-0048 | |
| dc.identifier.other | 10.2144/fsoa-2022-0048 - C 202 | |
| dc.identifier.uri | http://repository.msa.edu.eg/xmlui/handle/123456789/5414 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Taylor and Francis Ltd. | en_US |
| dc.relation.ispartofseries | Future Science OA ; 16(3-06):FSO832 | |
| dc.subject | diagnostic tools • | en_US |
| dc.subject | epitope-based vaccines • | en_US |
| dc.subject | epitope mapping • | en_US |
| dc.subject | host-pathogen interface • | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.title | State of the art in epitope mapping and opportunities in COVID-19 | en_US |
| dc.type | Article | en_US |